Stay updated on AVP-786 for Traumatic Brain Injury Neurobehavioral Clinical Trial
Sign up to get notified when there's something new on the AVP-786 for Traumatic Brain Injury Neurobehavioral Clinical Trial page.

Latest updates to the AVP-786 for Traumatic Brain Injury Neurobehavioral Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 replaces the previous Revision: v3.2.0 on the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding lapse notice banner was removed from the page; the study details, outcomes, and contacts remain unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Results First Posted details (2025-10-29) and expanded the Study Plan with dosing regimens, outcomes, and IPD sharing information. Updated AVP-786 dosing descriptions (AVP-786-28/4.9 and AVP-786-42.63/4.9) and added comprehensive outcome measures (NPI-C subscales, mCGI-S, PGI-S/PGI-C, and mCGI-C).SummaryDifference4%

- Check63 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

- Check84 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 was added; the old revision label and a Back to Top link were removed, with no other substantive changes.SummaryDifference0.2%

Stay in the know with updates to AVP-786 for Traumatic Brain Injury Neurobehavioral Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 for Traumatic Brain Injury Neurobehavioral Clinical Trial page.